These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 38536747)

  • 1. Case weighted power priors for hybrid control analyses with time-to-event data.
    Kwiatkowski E; Zhu J; Li X; Pang H; Lieberman G; Psioda MA
    Biometrics; 2024 Mar; 80(2):. PubMed ID: 38536747
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Conditional borrowing external data to establish a hybrid control arm in randomized clinical trials.
    Li H; Tiwari R; Li QH
    J Biopharm Stat; 2022 Nov; 32(6):954-968. PubMed ID: 35067183
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Augmenting external control arms using Bayesian borrowing: a case study in first-line non-small cell lung cancer.
    Struebing A; McKibbon C; Ruan H; Mackay E; Dennis N; Velummailum R; He P; Tanaka Y; Xiong Y; Springford A; Rosenlund M
    J Comp Eff Res; 2024 May; 13(5):e230175. PubMed ID: 38573331
    [No Abstract]   [Full Text] [Related]  

  • 4. Incorporating individual historical controls and aggregate treatment effect estimates into a Bayesian survival trial: a simulation study.
    Brard C; Hampson LV; Gaspar N; Le Deley MC; Le Teuff G
    BMC Med Res Methodol; 2019 Apr; 19(1):85. PubMed ID: 31018832
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adaptively leveraging external data with robust meta-analytical-predictive prior using empirical Bayes.
    Zhang H; Shen Y; Li J; Ye H; Chiang AY
    Pharm Stat; 2023; 22(5):846-860. PubMed ID: 37220997
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 7. On efficient posterior inference in normalized power prior Bayesian analysis.
    Han Z; Zhang Q; Wang M; Ye K; Chen MH
    Biom J; 2023 Jun; 65(5):e2200194. PubMed ID: 36960489
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Modified power prior with multiple historical trials for binary endpoints.
    Banbeta A; van Rosmalen J; Dejardin D; Lesaffre E
    Stat Med; 2019 Mar; 38(7):1147-1169. PubMed ID: 30360016
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Simulating and reporting frequentist operating characteristics of clinical trials that borrow external information: Towards a fair comparison in case of one-arm and hybrid control two-arm trials.
    Kopp-Schneider A; Wiesenfarth M; Held L; Calderazzo S
    Pharm Stat; 2024; 23(1):4-19. PubMed ID: 37632266
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A novel power prior approach for borrowing historical control data in clinical trials.
    Shi Y; Li W; Liu GF
    Stat Methods Med Res; 2023 Mar; 32(3):493-508. PubMed ID: 36601652
    [TBL] [Abstract][Full Text] [Related]  

  • 11. BEATS: Bayesian hybrid design with flexible sample size adaptation for time-to-event endpoints.
    Bi D; Liu M; Lin J; Liu R
    Stat Med; 2023 Dec; 42(30):5708-5722. PubMed ID: 37858287
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Propensity-score-based meta-analytic predictive prior for incorporating real-world and historical data.
    Liu M; Bunn V; Hupf B; Lin J; Lin J
    Stat Med; 2021 Sep; 40(22):4794-4808. PubMed ID: 34126656
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The power prior: theory and applications.
    Ibrahim JG; Chen MH; Gwon Y; Chen F
    Stat Med; 2015 Dec; 34(28):3724-49. PubMed ID: 26346180
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Constructing Relative Effect Priors for Research Prioritization and Trial Design: A Meta-epidemiological Analysis.
    Glynn D; Nikolaidis G; Jankovic D; Welton NJ
    Med Decis Making; 2023 Jul; 43(5):553-563. PubMed ID: 37057388
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Using horseshoe prior for incorporating multiple historical control data in randomized controlled trials.
    Ohigashi T; Maruo K; Sozu T; Gosho M
    Stat Methods Med Res; 2022 Jul; 31(7):1392-1404. PubMed ID: 35379046
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bayesian adaptive randomization design incorporating propensity score-matched historical controls.
    Sawamoto R; Oba K; Matsuyama Y
    Pharm Stat; 2022 Sep; 21(5):1074-1089. PubMed ID: 35278032
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Utility of propensity score-based Bayesian borrowing of external adult data in pediatric trials: A pragmatic evaluation through a case study in acute lymphoblastic leukemia (ALL).
    Majumdar A; Rothwell R; Reaman G; Ahlberg C; Roy P
    J Biopharm Stat; 2023 Nov; 33(6):737-751. PubMed ID: 36600441
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A simulation study comparing the power of nine tests of the treatment effect in randomized controlled trials with a time-to-event outcome.
    Royston P; B Parmar MK
    Trials; 2020 Apr; 21(1):315. PubMed ID: 32252820
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A scaled kernel density estimation prior for dynamic borrowing of historical information with application to clinical trial design.
    Warren JL; Wang Q; Ciarleglio MM
    Stat Med; 2024 Apr; 43(8):1615-1626. PubMed ID: 38345148
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bayesian semiparametric meta-analytic-predictive prior for historical control borrowing in clinical trials.
    Hupf B; Bunn V; Lin J; Dong C
    Stat Med; 2021 Jun; 40(14):3385-3399. PubMed ID: 33851441
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.